LEADER 04511nam 2201129z- 450 001 9910580209103321 005 20220706 035 $a(CKB)5690000000011997 035 $a(oapen)https://directory.doabooks.org/handle/20.500.12854/87502 035 $a(oapen)doab87502 035 $a(EXLCZ)995690000000011997 100 $a20202207d2022 |y 0 101 0 $aeng 135 $aurmn|---annan 181 $ctxt$2rdacontent 182 $cc$2rdamedia 183 $acr$2rdacarrier 200 00$aMechanisms and Novel Therapeutic Approaches for Gynecologic Cancer 210 $aBasel$cMDPI - Multidisciplinary Digital Publishing Institute$d2022 215 $a1 online resource (258 p.) 311 08$a3-0365-4383-X 311 08$a3-0365-4384-8 330 $aThis book-entitled "Mechanisms and Novel Therapeutic Approaches for Gynecologic Cancer"-was edited as a Special Issue of Biomedicines, focusing on basic research such as genomics, epigenomics, and proteomics, as well as clinical research in the field of gynecologic oncology. The number of patients with gynecological cancer has been increasing worldwide due to its high lethality and lack of early detection tools and effective therapeutic interventions. In this regard, basic research on its pathophysiology and novel molecular targeting intervention is required to improve the prognosis of gynecologic cancer. This book contains 13 papers, including 8 original research papers and 5 reviews focusing on the basic research of gynecologic oncology. The reader can learn about state-of-the-art research and obtain extensive knowledge of the current advances in the field of gynecologic oncology. It is my hope that this book contributes towards the progress of gynecologic oncology. 606 $aPublic health and preventive medicine$2bicssc 610 $aadoptive immunotherapy 610 $aanti-angiogenic therapy 610 $aaryl hydrocarbon receptor 610 $aBEN (BANP, E5R and NAC1) domain 610 $abiological planning 610 $abiomarkers 610 $aborderline ovarian tumors 610 $aBRCA1 mutant ovarian cancer 610 $acancer progression 610 $aCD44 610 $acervical cancer 610 $acervical neoplasia 610 $achimeric antigen receptor 610 $aclear cell carcinoma 610 $adifferentially expressed genes 610 $aDNA damage response 610 $aDNA mismatch repair (MMR) 610 $adrug repurposing 610 $aendometrial cancer 610 $aendometrial carcinoma 610 $aendometrioid endometrial cancer 610 $aepithelial ovarian cancer 610 $aepithelial ovarian cancers 610 $aepithelial-mesenchymal transition 610 $aexosome 610 $agene ontology 610 $agynecological cancer 610 $aHDR brachytherapy 610 $ahuman cytomegalovirus 610 $aimmune checkpoints inhibitors 610 $aimmune micro-environment 610 $aimmunohistochemistry 610 $aimmunosuppression 610 $ain vivo dosimetry 610 $ainflammation 610 $aintegrative analysis 610 $ainterventional radiotherapy 610 $aisothermal titration calorimetry (ITC) 610 $aliquid biopsy 610 $along-term survival 610 $amelanoma treatment 610 $amicrosatellite instability 610 $amiRNA 610 $amismatch repair deficiency 610 $aMMR deficient (dMMR) 610 $an/a 610 $ananocarriers 610 $aNK cells 610 $anon-coding RNAs 610 $anucleus accumbens-associated protein 1 (NAC1) 610 $aovarian cancer 610 $ap16 protein 610 $apGSK3? 610 $aPLA2G7) 610 $aplatelet-activating factor acetylhydrolase (PAF-AH 610 $aprognosis 610 $asequence-specific DNA-binding protein 610 $asolution NMR structure 610 $asomatic mutation 610 $atargeted therapy 610 $atestin 610 $avaginal melanoma 610 $avaginal-cuff brachytherapy 610 $avulvar melanoma 610 $aWnt signaling 610 $a?-catenin 615 7$aPublic health and preventive medicine 700 $aNakayama$b Naomi$4edt$01326272 702 $aNakayama$b Naomi$4oth 906 $aBOOK 912 $a9910580209103321 996 $aMechanisms and Novel Therapeutic Approaches for Gynecologic Cancer$93037242 997 $aUNINA